Blue Bell Private Wealth Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7
| Closed | -$69 | – | 731 |
|
|
2024
Q4 | $69 | Hold |
7
| – | – | ﹤0.01% | 671 |
|
|
2024
Q3 | $57 | Sell |
7
-1
| -13% | -$8 | ﹤0.01% | 683 |
|
|
2024
Q2 | $100 | Hold |
8
| – | – | ﹤0.01% | 709 |
|
|
2024
Q1 | $348 | Hold |
8
| – | – | ﹤0.01% | 711 |
|
|
2023
Q4 | $507 | Hold |
8
| – | – | ﹤0.01% | 701 |
|
|
2023
Q3 | $543 | Hold |
8
| – | – | ﹤0.01% | 657 |
|
|
2023
Q2 | $558 | Hold |
8
| – | – | ﹤0.01% | 670 |
|
|
2023
Q1 | $399 | Hold |
8
| – | – | ﹤0.01% | 651 |
|
|
2022
Q4 | $507 | Hold |
8
| – | – | ﹤0.01% | 672 |
|
|
2022
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 654 |
|
|
2022
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 701 |
|
|
2022
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 762 |
|
|
2021
Q4 | $2K | Buy |
+8
| New | +$2K | ﹤0.01% | 663 |
|